Lymphedema a primer on the identification and management of a chronic condition in oncologic treatment ca cancer j clin jan feb 20095918 24 doi 103322 caac20001 authors brian d lawenda 1 tammy e mondry peter a s johnstone affiliation 1 radiation . Enticing readable and visually informative a primer on lymphedema is the first north american text on lymphedema a comprehensive resource for both novice and experienced clinicians alike its broad scope of coverage provides relevant information that encompasses all health care fields. Cdt is a two phase program that consists of a treatment phase and a maintenance phase phase 1 the treatment phase lasts 2 to 4 weeks in duration during this time the patient receives treatment on a daily basis 5 days per week with girth and volume measurements of the limb performed at the end of each week. Primary lymphedema is an autosomal dominant disease which means a person has a 50 50 chance of inheriting the mutated lymphedema causing gene from a parent with primary lymphedema the parent carrying the mutated gene may not visibly have primary lymphedema however as the gene has incomplete penetrance the genetic mutation can be inherited but not expressed